221 related articles for article (PubMed ID: 23493869)
1. Cosolvent effects on the fibrillation reaction of human IAPP.
Seeliger J; Estel K; Erwin N; Winter R
Phys Chem Chem Phys; 2013 Jun; 15(23):8902-7. PubMed ID: 23493869
[TBL] [Abstract][Full Text] [Related]
2. Amyloidogenic propensities and conformational properties of ProIAPP and IAPP in the presence of lipid bilayer membranes.
Jha S; Sellin D; Seidel R; Winter R
J Mol Biol; 2009 Jun; 389(5):907-20. PubMed ID: 19427320
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of membrane models and their composition for islet amyloid polypeptide-membrane aggregation.
Caillon L; Lequin O; Khemtémourian L
Biochim Biophys Acta; 2013 Sep; 1828(9):2091-8. PubMed ID: 23707907
[TBL] [Abstract][Full Text] [Related]
4. Effect of pressure on islet amyloid polypeptide aggregation: revealing the polymorphic nature of the fibrillation process.
Radovan D; Smirnovas V; Winter R
Biochemistry; 2008 Jun; 47(24):6352-60. PubMed ID: 18498175
[TBL] [Abstract][Full Text] [Related]
5. Low pH acts as inhibitor of membrane damage induced by human islet amyloid polypeptide.
Khemtémourian L; Doménech E; Doux JP; Koorengevel MC; Killian JA
J Am Chem Soc; 2011 Oct; 133(39):15598-604. PubMed ID: 21870807
[TBL] [Abstract][Full Text] [Related]
6. Comparative molecular dynamics study of human islet amyloid polypeptide (IAPP) and rat IAPP oligomers.
Liang G; Zhao J; Yu X; Zheng J
Biochemistry; 2013 Feb; 52(6):1089-100. PubMed ID: 23331123
[TBL] [Abstract][Full Text] [Related]
7. Suppression of IAPP fibrillation at anionic lipid membranes via IAPP-derived amyloid inhibitors and insulin.
Sellin D; Yan LM; Kapurniotu A; Winter R
Biophys Chem; 2010 Aug; 150(1-3):73-9. PubMed ID: 20153100
[TBL] [Abstract][Full Text] [Related]
8. Disaggregation of Islet Amyloid Polypeptide Fibrils as a Potential Anti-Fibrillation Mechanism of Tetrapeptide TNGQ.
Abioye RO; Okagu OD; Udenigwe CC
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216095
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of islet amyloid polypeptide fibrillation at lipid interfaces studied by infrared reflection absorption spectroscopy.
Lopes DH; Meister A; Gohlke A; Hauser A; Blume A; Winter R
Biophys J; 2007 Nov; 93(9):3132-41. PubMed ID: 17660321
[TBL] [Abstract][Full Text] [Related]
10. In silico studies of the human IAPP in the presence of osmolytes.
Khan A; Jahan I; Nayeem SM
J Mol Model; 2022 Jun; 28(7):188. PubMed ID: 35697975
[TBL] [Abstract][Full Text] [Related]
11. The role of protein sequence and amino acid composition in amyloid formation: scrambling and backward reading of IAPP amyloid fibrils.
Sabaté R; Espargaró A; de Groot NS; Valle-Delgado JJ; Fernàndez-Busquets X; Ventura S
J Mol Biol; 2010 Nov; 404(2):337-52. PubMed ID: 20887731
[TBL] [Abstract][Full Text] [Related]
12. Binding of islet amyloid polypeptide to supported lipid bilayers and amyloid aggregation at the membranes.
Sasahara K; Morigaki K; Okazaki T; Hamada D
Biochemistry; 2012 Sep; 51(35):6908-19. PubMed ID: 22876830
[TBL] [Abstract][Full Text] [Related]
13. Ferret islet amyloid polypeptide (IAPP): characterization of in vitro and in vivo amyloidogenicity.
Paulsson JF; Benoit-Biancamano MO; Schäffer L; Dahl K
Amyloid; 2011 Dec; 18(4):222-8. PubMed ID: 22047620
[TBL] [Abstract][Full Text] [Related]
14. Islet amyloid polypeptide: aggregation and fibrillogenesis in vitro and its inhibition.
Seeliger J; Winter R
Subcell Biochem; 2012; 65():185-209. PubMed ID: 23225004
[TBL] [Abstract][Full Text] [Related]
15. Fluorescence microscopy studies on islet amyloid polypeptide fibrillation at heterogeneous and cellular membrane interfaces and its inhibition by resveratrol.
Radovan D; Opitz N; Winter R
FEBS Lett; 2009 May; 583(9):1439-45. PubMed ID: 19344717
[TBL] [Abstract][Full Text] [Related]
16. The effect of Aβ on IAPP aggregation in the presence of an isolated β-cell membrane.
Seeliger J; Weise K; Opitz N; Winter R
J Mol Biol; 2012 Aug; 421(2-3):348-63. PubMed ID: 22321797
[TBL] [Abstract][Full Text] [Related]
17. Identification of a novel human islet amyloid polypeptide beta-sheet domain and factors influencing fibrillogenesis.
Jaikaran ET; Higham CE; Serpell LC; Zurdo J; Gross M; Clark A; Fraser PE
J Mol Biol; 2001 May; 308(3):515-25. PubMed ID: 11327784
[TBL] [Abstract][Full Text] [Related]
18. Membrane permeabilization by Islet Amyloid Polypeptide.
Engel MF
Chem Phys Lipids; 2009 Jul; 160(1):1-10. PubMed ID: 19501206
[TBL] [Abstract][Full Text] [Related]
19. Elucidating the mechanism of lipid membrane-induced IAPP fibrillogenesis and its inhibition by the red wine compound resveratrol: a synchrotron X-ray reflectivity study.
Evers F; Jeworrek C; Tiemeyer S; Weise K; Sellin D; Paulus M; Struth B; Tolan M; Winter R
J Am Chem Soc; 2009 Jul; 131(27):9516-21. PubMed ID: 19583433
[TBL] [Abstract][Full Text] [Related]
20. Engineered aggregation inhibitor fusion for production of highly amyloidogenic human islet amyloid polypeptide.
Mirecka EA; Gremer L; Schiefer S; Oesterhelt F; Stoldt M; Willbold D; Hoyer W
J Biotechnol; 2014 Dec; 191():221-7. PubMed ID: 24928165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
